News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.

Subscribe

Our U.S. Offices Are Closed

Our U.S. offices are closed in observance of Thanksgiving. We will reopen on Monday, December 1st.

Thank you for your patience.

To Purchase # 12819S

12819S 5 mg $109.00
$ 0. 00

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Western blot analysis of C2C12 cell extracts, untreated (-) or treated with Tunicamycin (2 μg/ml, 8 hr; +), using CHOP (D46F1) Rabbit mAb #5554 (upper) or β-Actin Antibody #4967 (lower).

Learn more about how we get our images

Chemical structure of Tunicamycin.

Learn more about how we get our images
Image

Product Usage Information

Tunicamycin is supplied as a lyophilized powder. For a 5 mg/ml stock, reconstitute the 5 mg in 1 ml DMSO. Working concentrations and length of treatments vary depending on the desired effect, but it is typically used at 0.1-10 μg/ml for 0.5-20 hours.

Solubility: Soluble in DMSO, DMF or Pyridine.


Storage: Store lyophilized at room temperature or in solution at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight:

840.9 g/mol


Purity:

>99%


Molecular Formula:

Homolog A: C37H60N4O16

Homolog B: C38H62N4O16

Homolog C: C39H64N4O16

Homolog D: C40H66N4O16


Isolated from Streptomyces lysosuperificus, tunicamycin is a nucleoside antibiotic that inhibits N-linked glycosylation in glycoprotein synthesis. Composed of tunicamycins A, B, C and D, the compound competitively blocks the transfer of N-acetylglucosamine-1-phosphate (GlcNAc-1-P) from UDP-GlcNAc to dolichol-P (1,2). By preventing glycoprotein synthesis, tunicamycin inhibits the formation of the “viral coat” known as the tunica or capsid in both RNA and DNA viruses, and thus exhibits antiviral properties (3). Research studies have shown that tunicamycin will arrest cells in G1 phase, preventing them from entering S-phase and increasing the expression of PERK (4,5). Following N-linked glycosylation inhibition, tunicamycin induces autophagy in response to ER stress, ultimately upregulating CHOP and BIP (6,7).


1.  Takatsuki, A. et al. (1971) J Antibiot (Tokyo) 24, 215-23.

2.  Kaushal, G.P. and Elbein, A.D. (1986) Plant Physiol 82, 748-52.

3.  Hirano, T. et al. (1982) J Biochem 92, 765-73.

4.  Brewer, J.W. and Diehl, J.A. (2000) Proc Natl Acad Sci U S A 97, 12625-30.

5.  Harding, H.P. et al. (1999) Nature 397, 271-4.

6.  Ding, W.X. et al. (2007) J Biol Chem 282, 4702-10.

7.  Zinszner, H. et al. (1998) Genes Dev 12, 982-95.



For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.